Get started
Author

Matthias Papo

Observed names: M. Papo, Matthias Papo-Darmon, Papo M, Papo, Matthias, Papo-Darmon, Matthias, Papo1, Matthias
Institutions: Inserm, Sorbonne Université, Hôpital Cochin, Assistance Publique – Hôpitaux de Paris, Pitié-Salpêtrière Hospital, Centre d'Immunologie et des Maladies Infectieuses
Observed institutions: Centre National de la Recherche Scientifique, Inserm, Université Paris Cité, Centre Hospitalier Universitaire Henri-Mondor, Sorbonne Université, Hôpital Cochin, Assistance Publique – Hôpitaux de Paris, CHU Dijon Bourgogne, Pitié-Salpêtrière Hospital, Centre d'Immunologie et des Maladies Infectieuses, Hôpitaux Universitaires Henri-Mondor, Hôpital Saint-Louis, Hôpital Bichat-Claude-Bernard, Institut des Maladies Génétiques Imagine, Hôpital Tenon, Université Paris Diderot, Université Paris Descartes, Université Pierre-et-Marie-Curie, Paris-Sorbonne University
ORCID: 0000-0003-3389-9473
Observed ORCID: 0000-0003-3389-9473
OpenAlex ID: A5081687115
High prevalence of myeloid neoplasms in adults with non–Langerhans cell histiocytosis
2017 · Matthias Papo, Eli L. Diamond, et al. · Blood · 152
Functional evidence for derivation of systemic histiocytic neoplasms from hematopoietic stem/progenitor cells
2017 · Benjamin H. Durham, Damien Roos-Weil, et al. · Blood · 135
PDF
Erdheim–Chester disease: a rapidly evolving disease model
2020 · Francesco Pegoraro, Matthias Papo, et al. · Leukemia · 80
Systemic Histiocytosis (Langerhans Cell Histiocytosis, Erdheim–Chester Disease, Destombes–Rosai–Dorfman Disease): from Oncogenic Mutations to Inflammatory Disorders
2019 · Matthias Papo, Fleur Cohen-Aubart, et al. · Current Oncology Reports · 77
Erdheim-Chester Disease: a Concise Review
2019 · Matthias Papo, Jean-François Emile, et al. · Current Rheumatology Reports · 74
Tocilizumab in severe and refractory non-infectious uveitis.
2014 · Matthias Papo, Philip Bielefeld, et al. · PubMed · 72
Significance of PR3-ANCA positivity in eosinophilic granulomatosis with polyangiitis (Churg-Strauss)
2020 · Matthias Papo, Renato A. Sinico, et al. · Lara D. Veeken · 55
Long-term outcome and prognosis of mixed histiocytosis (Erdheim-Chester disease and Langerhans Cell Histiocytosis)
2024 · Francesco Pegoraro, Matthias Papo, et al. · EClinicalMedicine · 25
La maladie d’Erdheim-Chester, une néoplasie myéloïde inflammatoire
2016 · Julien Haroche, Matthias Papo, et al. · La Presse Médicale · 23
Myeloproliferative neoplasms and clonal haematopoiesis in patients with giant cell arteritis: a case–control and exploratory study
2021 · Matthias Papo, Chloé Friedrich, et al. · Lara D. Veeken · 21
Renal replacement therapy during Stevens-Johnson syndrome and toxic epidermal necrolysis: a retrospective observational study of 238 patients
2016 · M. Papo, L. Valeyrie-Allanore, et al. · British Journal of Dermatology · 16
Clinical and prognostic significance of antinuclear antibodies in primary antiphospholipid syndrome: A multicenter retrospective study
2021 · Laure Ricard, Charlotte Laurent, et al. · Joint Bone Spine · 14
PDF
L’hématopoïèse clonale : un concept émergent à la croisée des spécialités
2019 · F.-X. Danlos, M. Papo, et al. · La Revue de Médecine Interne · 14
PDF
Epidemiology and geographic clustering of Erdheim-Chester disease in Italy and France
2023 · Francesco Peyronel, Julien Haroche, et al. · Blood · 13
PDF
Sequential disseminated aspergillosis and pulmonary tuberculosis in a patient treated by idelalisib for chronic lymphocytic leukemia
2016 · B. Lafon-Desmurs, G. Monsel, et al. · Médecine et Maladies Infectieuses · 11
Glucocorticoids versus glucocorticoids plus cyclophosphamide in eosinophilic granulomatosis with polyangiitis with poor-prognosis factors
2024 · Boris Sorin, Matthias Papo, et al. · Journal of Autoimmunity · 10
Cluster analysis reveals the clinical spectrum of Erdheim-Chester disease
2025 · Michelangelo Tesi, Francesco Pegoraro, et al. · Leukemia · 8
MEK inhibitors are effective in Erdheim–Chester disease regardless of MAPK pathway mutations
2025 · Francesco Pegoraro, Fleur Cohen-Aubart, et al. · Leukemia · 8
PDF
Risk of flare in patients with SLE in remission after hydroxychloroquine or chloroquine withdrawal
2024 · Ludovic Trefond, Alexis Mathian, et al. · Joint Bone Spine · 8
Identification of new risk factors for hydroxychloroquine and chloroquine retinopathy in systemic lupus erythematosus patients
2024 · Ludovic Trefond, Ludovic Trefond, et al. · Seminars in Arthritis and Rheumatism · 7
Genome‐Wide Association Study Identifies the First Germline Genetic Variant Associated With Erdheim‐Chester Disease
2023 · Javier Martínez‐López, Ana Márquez, et al. · Arthritis & Rheumatology · 7
PDF
Immune phenotyping of Erdheim-Chester disease through mass cytometry highlights decreased proportion of non-classical monocytes and increased proportion of Th17 cells
2020 · Matthias Papo, Aurélien Corneau, et al. · Annals of the Rheumatic Diseases · 6
Performance of SCORE2, QRISK3 and PREVENT equations in systemic lupus erythematosus
2025 · Lévi-Dan Azoulay, Thomas Broussaud, et al. · Lupus · 5
PDF
Glucocorticoids vs glucocorticoids plus cyclophosphamide in eosinophilic granulomatosis with polyangiitis without poor-prognosis factors: a target trial emulation study
2025 · Boris Sorin, Matthias Papo, et al. · Lara D. Veeken · 5
Prognostic value of CT-derived epicardial adipose tissue volume over coronary artery calcium in systemic lupus erythematosus
2025 · Lévi-Dan Azoulay, Nadjia Kachenoura, et al. · European Journal of Preventive Cardiology · 4
PDF
Works count: 127
Citation count: 896
H-index: 13
I10-index: 16
Year
Topic
Type